Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Cellsight Technologies, Inc., explained in plain language.
This small Phase 1 study tested whether a radioactive tracer called [18F]F-AraG can help detect graft-versus-host disease (GVHD) using PET scans. GVHD is a serious condition where donor immune cells attack the recipient's body after a stem cell transplant. The study involved 9 pa…
Phase: PHASE1 • Sponsor: CellSight Technologies, Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 08:03 UTC